Coles N Anthony's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Sep 17, 2021
- Accession no.
- 0001237899-21-000022
- Filed
- Sep 17, 2021
- Trade date
- Sep 15, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 15 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.87M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coles N AnthonyCIK 0001197018 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | Common Stock | MOption exerciseAcquired | +6,909 | $380.95 | +$2,631,983.55 | 7,811 | Direct | |
| Sep 15, 2021 | Common Stock | MOption exerciseAcquired | +5,039 | $345.47 | +$1,740,823.33 | 12,850 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −300 | $651.36 | −$195,408 | 12,550 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −1,101 | $652.95F2 | −$718,897.95 | 11,449 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −800 | $653.31F3 | −$522,648 | 10,649 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −403 | $655.14F4 | −$264,021.42 | 10,246 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −1,400 | $656.48F5 | −$919,072 | 8,846 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −835 | $657.53 | −$549,037.55 | 8,011 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −935 | $658.65 | −$615,837.75 | 7,076 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −300 | $659.00 | −$197,700 | 6,776 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −448 | $660.78F6 | −$296,029.44 | 6,328 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −3,344 | $661.56F7 | −$2,212,256.64 | 2,984 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −3 | $662.55 | −$1,987.65 | 2,981 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −905 | $663.73F8 | −$600,675.65 | 2,076 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −1,174 | $664.32F9 | −$779,911.68 | 902 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | Common Stock | MOption exerciseDisposed | −5,039 | $0.00 | $0 | 0 | Direct | |
| Sep 15, 2021 | Common Stock | MOption exerciseDisposed | −6,909 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents volume-weighted average price of sales of 1,101 shares of Company stock on September 15, 2021 at prices ranging from $652.48 to $652.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 800 shares of Company stock on September 15, 2021 at prices ranging from $653.11 to $653.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 403 shares of Company stock on September 15, 2021 at prices ranging from $655.14 to $655.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 1,400 shares of Company stock on September 15, 2021 at prices ranging from $656.18 to $656.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 448 shares of Company stock on September 15, 2021 at prices ranging from $660.29 to $660.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 3,344 shares of Company stock on September 15, 2021 at prices ranging from $661.02 to $661.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 905 shares of Company stock on September 15, 2021 at prices ranging from $663.15 to $663.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 1,174 shares of Company stock on September 15, 2021 at prices ranging from $664.00 to $664.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.